P1.07-025 Correlating ISEND and Tumor Mutation Burden (TMB) with Clinical Outcomes of Advanced Non-Small Cell Lung Cancer (ANSCLC) Patients on Nivolumab

著录项

• 来源
  《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第11期|共2页
• 作者

  W. Park; G. Lopes; D. Kwon; V. Florou; Y.K. Chae; J. Warsch; A. Ishkanian; M. Jahanzeb; R. Mudad;

  展开▼
• 作者单位

  Hematology and Oncology University of Miami Sylvester Comprehensive Cancer Center;

  Hematology and Oncology University of Miami Sylvester Comprehensive Cancer Center;

  Department of Medicine Biostatistics and Bioinformatics University of Miami Sylvester;

  Hematology and Oncology University of Miami Sylvester Comprehensive Cancer Center;

  Developmental Therapeutics Program of the Division of Hematology Oncology Robert H Lurie;

  Radiology University of Miami Sylvester Comprehensive Cancer Center;

  Radiation Oncology University of Miami Sylvester Comprehensive Cancer Center;

  Medical Oncology University of Miami Sylvester Comprehensive Cancer Center;

  Hematology and Oncology University of Miami Sylvester Comprehensive Cancer Center;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词